// App-Quantinova.ai

: Incremental prognostic value of cardiac biomarkers in diagnostically naive patients with suspected heart failure - comparison with a clinical base model

Researchers

Presenter

  • S. Demirbas

Principal Investigators

  • C. Morbach

  • D. Oder

  • V. Holzendorf

  • C. Prettin

  • J.O. Vollert

  • S. Stoerk

  • G. Ertl

  • C.E. Angermann

Medical Centers

  • University Hospital Wuerzburg and Comprehensive Heart Failure Center (CHFC), Department of Internal Medicine I, Wuerzburg, Germany

  • University Hospital Leipzig, Clinical Trial Centre Leipzig - KKS, Leipzig, Germany

  • B.R.A.H.M.S GmbH, Thermo Scientific Clinical Diagnostics, Berlin, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • B-type natriuretic peptide

  • High sensitivity C-reactive protein

  • Tumor necrosis factor

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved